Free Trial

Mn Services Vermogensbeheer B.V. Sells 8,000 Shares of Docusign Inc. (NASDAQ:DOCU)

Docusign logo with Computer and Technology background

Mn Services Vermogensbeheer B.V. cut its stake in Docusign Inc. (NASDAQ:DOCU - Free Report) by 9.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,100 shares of the company's stock after selling 8,000 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in Docusign were worth $6,032,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Optas LLC increased its holdings in shares of Docusign by 7.6% during the 1st quarter. Optas LLC now owns 3,088 shares of the company's stock valued at $251,000 after purchasing an additional 219 shares in the last quarter. Ritholtz Wealth Management increased its holdings in Docusign by 58.5% during the 1st quarter. Ritholtz Wealth Management now owns 3,926 shares of the company's stock worth $320,000 after purchasing an additional 1,449 shares during the period. Wealth Enhancement Advisory Services LLC boosted its position in shares of Docusign by 528.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 108,232 shares of the company's stock worth $8,810,000 after acquiring an additional 91,017 shares in the last quarter. Greenwood Capital Associates LLC acquired a new position in shares of Docusign during the 1st quarter worth about $784,000. Finally, Fifth Third Bancorp grew its stake in Docusign by 26.2% during the 1st quarter. Fifth Third Bancorp now owns 1,391 shares of the company's stock worth $113,000 after buying an additional 289 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Teresa Briggs sold 534 shares of Docusign stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $74.37, for a total value of $39,713.58. Following the completion of the sale, the director now directly owns 8,805 shares in the company, valued at $654,827.85. The trade was a 5.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Robert Chatwani sold 22,875 shares of the firm's stock in a transaction that occurred on Wednesday, June 18th. The stock was sold at an average price of $74.79, for a total transaction of $1,710,821.25. Following the completion of the transaction, the insider now directly owns 72,126 shares in the company, valued at approximately $5,394,303.54. The trade was a 24.08% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 54,052 shares of company stock valued at $4,101,776. Corporate insiders own 1.01% of the company's stock.

Analyst Upgrades and Downgrades

DOCU has been the subject of several research analyst reports. Morgan Stanley dropped their price objective on Docusign from $92.00 to $86.00 and set an "equal weight" rating for the company in a research note on Friday, June 6th. Bank of America lowered their price objective on Docusign from $88.00 to $85.00 and set a "neutral" rating for the company in a report on Friday, June 6th. Robert W. Baird reduced their price objective on Docusign from $93.00 to $85.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Royal Bank Of Canada reaffirmed a "sector perform" rating and issued a $90.00 price target on shares of Docusign in a report on Friday, March 14th. Finally, Wedbush cut their target price on shares of Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a research note on Thursday, June 12th. Twelve investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, Docusign has an average rating of "Hold" and a consensus target price of $89.77.

Check Out Our Latest Stock Analysis on Docusign

Docusign Price Performance

NASDAQ DOCU traded up $0.44 during mid-day trading on Thursday, reaching $75.25. 3,736,684 shares of the stock were exchanged, compared to its average volume of 2,866,307. Docusign Inc. has a one year low of $48.80 and a one year high of $107.86. The stock has a 50 day simple moving average of $82.18 and a 200-day simple moving average of $85.91. The stock has a market cap of $15.21 billion, a P/E ratio of 14.22, a P/E/G ratio of 28.54 and a beta of 1.14.

Docusign (NASDAQ:DOCU - Get Free Report) last released its earnings results on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.09. The firm had revenue of $763.65 million for the quarter, compared to analysts' expectations of $748.79 million. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The company's quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.82 earnings per share. Sell-side analysts anticipate that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign announced that its Board of Directors has authorized a stock repurchase program on Thursday, June 5th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 6.6% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board believes its stock is undervalued.

Docusign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines